ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 200 filers reported holding ANI PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,116,119 | +33.3% | 17,527 | +44.8% | 0.00% | +100.0% |
Q1 2024 | $837,026 | +231.4% | 12,108 | +164.3% | 0.00% | – |
Q4 2023 | $252,596 | -68.7% | 4,581 | -84.1% | 0.00% | -100.0% |
Q1 2022 | $808,000 | +128.2% | 28,738 | +274.2% | 0.00% | +100.0% |
Q4 2021 | $354,000 | -48.3% | 7,680 | -60.7% | 0.00% | 0.0% |
Q2 2021 | $685,000 | -8.9% | 19,542 | -6.1% | 0.00% | 0.0% |
Q1 2021 | $752,000 | -24.3% | 20,816 | -39.2% | 0.00% | -50.0% |
Q4 2020 | $994,000 | -8.0% | 34,240 | -10.7% | 0.00% | 0.0% |
Q3 2020 | $1,081,000 | -39.4% | 38,335 | -30.5% | 0.00% | -33.3% |
Q2 2020 | $1,784,000 | -27.5% | 55,166 | -8.7% | 0.00% | -25.0% |
Q1 2020 | $2,461,000 | +420.3% | 60,412 | +687.4% | 0.00% | +300.0% |
Q4 2019 | $473,000 | +39.5% | 7,672 | +64.7% | 0.00% | – |
Q3 2019 | $339,000 | -37.7% | 4,658 | -29.6% | 0.00% | -100.0% |
Q2 2019 | $544,000 | -4.6% | 6,619 | -18.1% | 0.00% | 0.0% |
Q1 2019 | $570,000 | +74.8% | 8,083 | +11.6% | 0.00% | – |
Q4 2018 | $326,000 | -41.2% | 7,240 | -26.1% | 0.00% | -100.0% |
Q3 2018 | $554,000 | +3.2% | 9,792 | +21.9% | 0.00% | 0.0% |
Q2 2018 | $537,000 | -6.0% | 8,035 | -18.1% | 0.00% | 0.0% |
Q1 2018 | $571,000 | +132.1% | 9,808 | +86.3% | 0.00% | – |
Q2 2017 | $246,000 | -6.1% | 5,264 | -0.6% | 0.00% | – |
Q1 2017 | $262,000 | +4.0% | 5,296 | +27.6% | 0.00% | – |
Q4 2016 | $252,000 | -62.8% | 4,152 | -65.8% | 0.00% | -100.0% |
Q2 2016 | $677,000 | +90.2% | 12,126 | +14.7% | 0.00% | 0.0% |
Q1 2016 | $356,000 | -37.9% | 10,568 | -16.7% | 0.00% | 0.0% |
Q4 2015 | $573,000 | -26.8% | 12,688 | -36.0% | 0.00% | -50.0% |
Q3 2015 | $783,000 | -65.0% | 19,829 | -45.0% | 0.00% | -50.0% |
Q2 2015 | $2,236,000 | -16.5% | 36,024 | -15.8% | 0.00% | -33.3% |
Q1 2015 | $2,678,000 | -55.6% | 42,805 | -60.0% | 0.01% | -53.8% |
Q4 2014 | $6,029,000 | +125.8% | 106,905 | +13.2% | 0.01% | +85.7% |
Q3 2014 | $2,670,000 | – | 94,400 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |